Invesco S&P 500 Equal Weight Health Care ETF
RSPH
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is an exchange-traded fund that seeks to track the investment results, before fees and expenses, of the S&P 500 Equal Weight Health Care Index by investing at least 90% of its total assets in common stocks comprising the index; the index equally weights approximately 60 health care sector stocks from the S&P 500 Index, with quarterly rebalancing, resulting in sector allocations including health care equipment and supplies (around 31%), health care providers and services (27%), life sciences tools and services (17%), biotechnology (13%), and pharmaceuticals (12%). Top holdings typically include companies such as Centene Corp., Pfizer Inc., West Pharmaceutical Services Inc., Becton Dickinson and Co., Edwards Lifesciences Corp., Eli Lilly and Co., Cardinal Health Inc., and Regeneron Pharmaceuticals Inc., each weighted at approximately 1.7-2.1% as of recent data, with total assets under management around $688-718 million. The fund pays quarterly dividends, with a recent yield of about 0.68-0.71% and the latest ex-dividend date in December 2024. Launched on November 1, 2006, RSPH is part of Invesco Exchange-Traded Fund Trust, domiciled in the United States with operations focused on U.S. investors and 100% allocation to U.S.-based health care equities targeting large-cap companies (over 93% of holdings). It serves investors seeking diversified exposure to the health care sector through an equal-weighting approach that reduces concentration risk compared to market-cap weighted peers. In recent developments, institutional investors including Wealth Enhancement Advisory Services LLC trimmed holdings by 19.5% in Q2 2025, while others like AE Wealth Management LLC increased stakes by 66.5% in Q1 2025; new positions were established by entities such as Avalon Trust Co., SVB Wealth LLC, North Capital Inc., and CX Institutional during early 2025. The fund maintained steady quarterly dividend growth of about 5.5% over the past year, with payments escalating from $0.04585 in March 2024 to $0.0569 in December 2024, amid analyst expectations for strong sector earnings growth of 21% in 2025 driven by receding inflation and a weakening job market. No major acquisitions, partnerships, or structural changes for the ETF itself were reported in the last 1-2 years, though broader health care sector dynamics position RSPH for potential outperformance in a lower interest rate environment.